Vident Investment Advisory’s Acadia Healthcare ACHC Stock Holding History

Vident Investment Advisory’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-39,822	Closed	-$2.69M	–	1116
2022 Q2	$2.69M	Buy	39,822 +3,013	+8%	+$210K	0.08%	288
2022 Q1	$2.41M	Buy	36,809 +1,611	+5%	+$93.6K	0.06%	372
2021 Q4	$2.14M	Buy	35,198 +1,432	+4%	+$85.4K	0.06%	426
2021 Q3	$2.15M	Sell	33,766 -3,371	-9%	-$213K	0.07%	365
2021 Q2	$2.33M	Sell	37,137 -131	-0.4%	-$8.21K	0.07%	341
2021 Q1	$2.13M	Buy	+37,268	New	+$2.02M	0.07%	348
2020 Q1	–	Sell	-90,923	Closed	-$3.02M	–	785
2019 Q4	$3.02M	Buy	90,923 +68,402	+304%	+$2.14M	0.19%	104
2019 Q3	$700K	Buy	+22,521	New	+$686K	0.06%	237
2019 Q1	–	Sell	-64,638	Closed	-$1.66M	–	697
2018 Q4	$1.66M	Sell	64,638 -6,504	-9%	-$225K	0.09%	297
2018 Q3	$2.5M	Buy	+71,142	New	+$2.83M	0.1%	285

Other funds holding ACHC

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vident Investment Advisory's ACHC Position: Q3 2022 in Review

Vident Investment Advisory sold out of Acadia Healthcare (ACHC) in Q3 2022, closing a stake of 39,822 shares — an estimated $2.69M sold.

Vident Investment Advisory first reported a position in ACHC in Q3 2018 and held it in 10 quarters. The position peaked at $3.02M in Q4 2019. 317 funds tracked by Wall St. Rank hold ACHC as of Q3 2022.

Vident Investment Advisory reported no remaining Acadia Healthcare position as of Q3 2022 after selling out during the quarter.
Vident Investment Advisory sold 39,822 Acadia Healthcare shares in Q3 2022, an estimated $2.69M.
Vident Investment Advisory first reported a position in Acadia Healthcare in Q3 2018 and held it in 10 quarters.
Vident Investment Advisory's Acadia Healthcare position peaked at $3.02M in Q4 2019.
317 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2022.

Based on Vident Investment Advisory's 13F filing for Q3 2022, filed 14 Nov 2022.